CORR Insights®: Postoperative Thromboprophylaxis With New Oral Anticoagulants is Superior to LMWH in Hip Arthroplasty Surgery: Findings from the Swedish Registry
Overview
Overview
Journal
Clin Orthop Relat Res
Publisher
Wolters Kluwer
Specialty
Orthopedics
Date
2019 May 29
PMID
31136432
Authors
Authors
Affiliations
Affiliations
Soon will be listed here.
Citing Articles
Abdelsalam A, Fikry M, Fahmy A, Hegazy T, Hamdy A, Refaat A Obes Surg. 2025; 35(3):934-940.
PMID: 39921824 PMC: 11906520. DOI: 10.1007/s11695-025-07721-y.
References
1.
Kim Y, Oh S, Kim J
. Incidence and natural history of deep-vein thrombosis after total hip arthroplasty. A prospective and randomised clinical study. J Bone Joint Surg Br. 2003; 85(5):661-5.
View
2.
Eriksson B, Dahl O, Rosencher N, Kurth A, van Dijk C, Frostick S
. Dabigatran etexilate versus enoxaparin for prevention of venous thromboembolism after total hip replacement: a randomised, double-blind, non-inferiority trial. Lancet. 2007; 370(9591):949-56.
DOI: 10.1016/S0140-6736(07)61445-7.
View
3.
Eriksson B, Borris L, Friedman R, Haas S, Huisman M, Kakkar A
. Rivaroxaban versus enoxaparin for thromboprophylaxis after hip arthroplasty. N Engl J Med. 2008; 358(26):2765-75.
DOI: 10.1056/NEJMoa0800374.
View
4.
Kubitza D, Becka M, Mueck W, Halabi A, Maatouk H, Klause N
. Effects of renal impairment on the pharmacokinetics, pharmacodynamics and safety of rivaroxaban, an oral, direct Factor Xa inhibitor. Br J Clin Pharmacol. 2010; 70(5):703-12.
PMC: 2997310.
DOI: 10.1111/j.1365-2125.2010.03753.x.
View
5.
Lassen M, Gallus A, Raskob G, Pineo G, Chen D, Ramirez L
. Apixaban versus enoxaparin for thromboprophylaxis after hip replacement. N Engl J Med. 2010; 363(26):2487-98.
DOI: 10.1056/NEJMoa1006885.
View